Innovent Biologics, Inc. (HKG:1801)
Hong Kong
· Delayed Price · Currency is HKD 84.90
+2.30 (2.78%)
Apr 29, 2026, 4:08 PM HKT
Innovent Biologics Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 143,327 | 132,265 | 59,956 | 69,333 | 51,403 | 70,547 | Upgrade
|
| Market Cap Growth | 74.45% | 120.60% | -13.53% | 34.88% | -27.14% | -38.71% | Upgrade
|
| Enterprise Value | 126,172 | 125,514 | 54,283 | 63,850 | 44,899 | 59,352 | Upgrade
|
| Last Close Price | 82.60 | 76.25 | 36.60 | 42.75 | 33.50 | 48.25 | Upgrade
|
| PE Ratio | 157.93 | 146.09 | - | - | - | - | Upgrade
|
| Forward PE | 43.59 | 42.67 | - | - | - | - | Upgrade
|
| PS Ratio | 9.88 | 9.11 | 5.98 | 10.14 | 9.98 | 13.46 | Upgrade
|
| PB Ratio | 6.65 | 6.14 | 4.30 | 5.02 | 4.24 | 5.56 | Upgrade
|
| P/TBV Ratio | 7.23 | 6.67 | 4.40 | 5.04 | 4.25 | 5.57 | Upgrade
|
| P/FCF Ratio | - | - | 175.32 | - | - | - | Upgrade
|
| P/OCF Ratio | - | - | 43.78 | 425.78 | - | - | Upgrade
|
| EV/Sales Ratio | 8.69 | 8.65 | 5.41 | 9.34 | 8.72 | 11.33 | Upgrade
|
| EV/EBITDA Ratio | 125.16 | 112.49 | 2126.28 | - | - | - | Upgrade
|
| EV/EBIT Ratio | 187.31 | 160.65 | - | - | - | - | Upgrade
|
| EV/FCF Ratio | - | - | 158.73 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.14 | 0.14 | 0.22 | 0.29 | 0.30 | 0.24 | Upgrade
|
| Debt / EBITDA Ratio | 2.81 | 2.81 | 50.93 | - | - | - | Upgrade
|
| Debt / FCF Ratio | - | - | 8.81 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.80 | -0.80 | -0.38 | -0.59 | -0.55 | -0.63 | Upgrade
|
| Net Debt / EBITDA Ratio | -15.37 | -15.37 | -210.62 | 5.70 | 2.06 | 2.57 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -15.72 | 7.56 | 2.11 | 2.11 | Upgrade
|
| Asset Turnover | 0.44 | 0.44 | 0.45 | 0.33 | 0.27 | 0.30 | Upgrade
|
| Inventory Turnover | 2.90 | 2.90 | 2.69 | 1.51 | 1.00 | 1.19 | Upgrade
|
| Quick Ratio | 2.38 | 2.38 | 2.08 | 2.68 | 2.78 | 3.27 | Upgrade
|
| Current Ratio | 2.63 | 2.63 | 2.35 | 3.00 | 3.29 | 3.79 | Upgrade
|
| Return on Equity (ROE) | 5.01% | 5.01% | -0.74% | -8.84% | -20.70% | -28.56% | Upgrade
|
| Return on Assets (ROA) | 1.49% | 1.49% | -0.82% | -5.12% | -11.54% | -12.04% | Upgrade
|
| Return on Invested Capital (ROIC) | 17.28% | 11.34% | -4.18% | -31.37% | -72.59% | -95.23% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.40% | 2.40% | -1.60% | -9.70% | -22.20% | -20.50% | Upgrade
|
| Earnings Yield | 0.63% | 0.68% | -0.17% | -1.63% | -4.79% | -4.75% | Upgrade
|
| FCF Yield | - | - | 0.57% | -1.54% | -6.19% | -5.38% | Upgrade
|
| Buyback Yield / Dilution | -6.98% | -6.98% | -4.35% | -4.67% | -2.37% | -7.27% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.